54
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Artificial Intelligence in Gastroenterology

      Submit here before May 31, 2024

      About Digestion: 3.2 Impact Factor I 6.4 CiteScore I 0.914 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version

      guideline

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death not only in Japan but also worldwide. Clinical practice guidelines for HCC were first published in 2001 by the European Society of Study of the Liver (EASL) followed by the American Association for the Study of Liver Disease (AASLD) published in 2005 and updated in 2010. However, these guidelines have proven to be somewhat unsuitable for Japanese patients. In 2005, supported by the Japanese Ministry of Health, Labour and Welfare, evidence-based clinical practice guidelines for HCC were compiled in Japan. In 2009, a revised version of evidence-based guidelines was published. Based on both ‘evidence-based’ guidelines and the consensus of an expert panel on HCC, the Japan Society of Hepatology (JSH) published the Consensus-Based Clinical Practice Manual in 2007 and updated in 2010. In this article, the 2010 updated version of this manual, especially issues on prevention, surveillance, pathology, diagnosis, staging, and treatment algorithm are summarized.

          Related collections

          Author and article information

          Journal
          DDI
          Dig Dis
          10.1159/issn.0257-2753
          Digestive Diseases
          S. Karger AG
          978-3-8055-9761-6
          978-3-8055-9762-3
          0257-2753
          1421-9875
          2011
          August 2011
          09 August 2011
          : 29
          : 3
          : 339-364
          Affiliations
          aDepartment of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka, bMusashino Red Cross Hospital, Musashino, cDepartment of Hepatobiliary and Pancreatic Surgery, University of Tokyo Graduate School of Medicine, Tokyo, dDepartment of Radiology, Kanazawa University Graduate School of Medical Science, Kanazawa, eDepartment of Pathology, Keio University School of Medicine, Tokyo, fDepartment of Pathology, Kurume University School of Medicine, Kurume, gDepartment of Kurume University School of Medicine, Kurume, and hDepartment of Surgery, Japanese Red Cross Medical Hospital, Tokyo, Japan
          Author notes
          *Masatoshi Kudo, MD, PhD, Department of Gastroenterology and Hepatology, Kinki University School of Medicine, 377-2, Ohno-Higashi, Osaka-Sayama, Osaka 589-8511 (Japan), Tel. +81 72 366 0221 ext. 3149, E-Mail m-kudo@med.kindai.ac.jp
          Article
          327577 Dig Dis 2011;29:339–364
          10.1159/000327577
          21829027
          01ad38b7-9967-4b6d-ba16-daf3326b695d
          © 2011 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          Page count
          Figures: 9, Tables: 15, Pages: 26
          Categories
          Paper

          Oncology & Radiotherapy,Gastroenterology & Hepatology,Surgery,Nutrition & Dietetics,Internal medicine
          Clinical practice manual, consensus-based,Hepatocellular carcinoma, surveillance,Hepatocellular carcinoma, treatment algorithm,Hepatocellular carcinoma, staging,Hepatocellular carcinoma, prevention,Clinical practice guidelines, evidence-based,Hepatocellular carcinoma, diagnostic algorithm

          Comments

          Comment on this article